These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 26802069

  • 21. [Nephrogenic systemic fibrosis and gadolinium contrast agents].
    Aguilera C, Agustí A.
    Med Clin (Barc); 2011 May 21; 136(14):643-5. PubMed ID: 21397280
    [No Abstract] [Full Text] [Related]

  • 22. Nephrogenic systemic fibrosis.
    Weinreb JC, Kuo PH.
    Magn Reson Imaging Clin N Am; 2009 Feb 21; 17(1):159-67. PubMed ID: 19364606
    [Abstract] [Full Text] [Related]

  • 23. Experimental studies investigating the pathophysiology of nephrogenic systemic fibrosis; what did we learn so far?
    Morcos SK.
    Eur Radiol; 2011 Mar 21; 21(3):496-500. PubMed ID: 20848109
    [No Abstract] [Full Text] [Related]

  • 24. [Gadolinium and nephrogenic systemic fibrosis. All quiet? Yes...! No...! Maybe...!].
    Balducci A, Tamburrini O.
    G Ital Nefrol; 2011 Mar 21; 28(1):4-6. PubMed ID: 21341233
    [No Abstract] [Full Text] [Related]

  • 25. Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?
    Lind Ramskov K, Thomsen HS.
    Acta Radiol; 2009 Nov 21; 50(9):965-7. PubMed ID: 19863403
    [No Abstract] [Full Text] [Related]

  • 26. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis.
    Bertero M, Bainotti S, Comino A, Formica M, Giordano F, Musso L, Palazzini S, Seia Z.
    Eur J Dermatol; 2009 Nov 21; 19(1):73-4. PubMed ID: 19171533
    [No Abstract] [Full Text] [Related]

  • 27. Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update.
    Jalandhara N, Arora R, Batuman V.
    Clin Pharmacol Ther; 2011 Jun 21; 89(6):920-3. PubMed ID: 21471962
    [No Abstract] [Full Text] [Related]

  • 28. Gadolinium-based contrast agents and nephrogenic systemic fibrosis: why did it happen and what have we learned?
    Weinreb JC, Abu-Alfa AK.
    J Magn Reson Imaging; 2009 Dec 21; 30(6):1236-9. PubMed ID: 19938035
    [Abstract] [Full Text] [Related]

  • 29. Renal function, nephrogenic systemic fibrosis and other adverse reactions associated with gadolinium-based contrast media.
    Canga A, Kislikova M, Martínez-Gálvez M, Arias M, Fraga-Rivas P, Poyatos C, de Francisco AL.
    Nefrologia; 2014 Dec 21; 34(4):428-38. PubMed ID: 25036056
    [Abstract] [Full Text] [Related]

  • 30. Ocular pathologic features and gadolinium deposition in nephrogenic systemic fibrosis.
    Barker-Griffith A, Goldberg J, Abraham JL.
    Arch Ophthalmol; 2011 May 21; 129(5):661-3. PubMed ID: 21555622
    [No Abstract] [Full Text] [Related]

  • 31. Can gadolinium be given safely to a patient on dialysis?
    Rodby RA.
    Semin Dial; 2011 May 21; 24(4):370-1. PubMed ID: 21801214
    [No Abstract] [Full Text] [Related]

  • 32. Gadolinium-induced nephrogenic systemic fibrosis: communication breakdown among specialists or intuitive stroke of genius?
    Kraetschmer K.
    Intern Med J; 2009 Jan 21; 39(1):70-2. PubMed ID: 19290991
    [No Abstract] [Full Text] [Related]

  • 33. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.
    Yee J.
    Adv Chronic Kidney Dis; 2017 May 21; 24(3):133-135. PubMed ID: 28501073
    [No Abstract] [Full Text] [Related]

  • 34. [Nephrogenic fibrosing dermatosis: From clinic to microscopy].
    Yoldez H, Ahlem B, Abderrahim E, Faten Z, Soumaya R.
    Nephrol Ther; 2018 Feb 21; 14(1):47-49. PubMed ID: 29239786
    [Abstract] [Full Text] [Related]

  • 35. Gadolinium accumulation after contrast-enhanced magnetic resonance imaging: what rheumatologists should know.
    Doniselli FM, Albano D, Chianca V, Cimmino MA, Sconfienza LM.
    Clin Rheumatol; 2017 May 21; 36(5):977-980. PubMed ID: 28321569
    [No Abstract] [Full Text] [Related]

  • 36. Renal failure and gadolinium. The number of documented cases is rising.
    Prescrire Int; 2008 Oct 21; 17(97):205. PubMed ID: 19537311
    [No Abstract] [Full Text] [Related]

  • 37. Canadian Association of Radiologists national advisory on gadolinium administration and nephrogenic systemic fibrosis.
    Padilla-Thornton A, Zand KR, Barrett B, Stein L, Andrew G, Forster BB.
    Can Assoc Radiol J; 2008 Dec 21; 59(5):237-40. PubMed ID: 19385151
    [No Abstract] [Full Text] [Related]

  • 38. Nephrogenic systemic fibrosis and class labeling of gadolinium-based contrast agents by the Food and Drug Administration.
    Yang L, Krefting I, Gorovets A, Marzella L, Kaiser J, Boucher R, Rieves D.
    Radiology; 2012 Oct 21; 265(1):248-53. PubMed ID: 22923714
    [Abstract] [Full Text] [Related]

  • 39. Case report. Appearance of nephrogenic fibrosing dermopathy on a bone scan.
    Su HS, Nazarian RM, Scott JA.
    Br J Radiol; 2009 Feb 21; 82(974):e35-6. PubMed ID: 19168688
    [Abstract] [Full Text] [Related]

  • 40. Gadolinium and nephrogenic systemic fibrosis: have the alarm bells been silenced?
    Tamburrini O, Balducci A.
    Radiol Med; 2012 Feb 21; 117(1):1-5. PubMed ID: 22020430
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.